Q2 2023 Holdings
Filed 2023-08-14 | 35 holdings | $147.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $27.1M | 297,596 | 18.4% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $12.6M | 1,849,402 | 8.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $8.5M | 970,000 | 5.8% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $7.5M | 709,118 | 5.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.3M | 299,841 | 4.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.2M | 139,500 | 4.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.1M | 122,166 | 4.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $6.1M | 306,194 | 4.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.3M | 224,707 | 3.6% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.2M | 131,454 | 3.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.9M | 12,568 | 3.3% |
| Praxis Precision Medicines I | COM | 74006W108 | $4.9M | 4,250,000 | 3.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $4.8M | 147,318 | 3.3% |
| Cymabay Therapeutics Inc. Common Stock(CBAYUSD) | COM | 23257D103 | $4.7M | 430,000 | 3.2% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $4.2M | 122,343 | 2.8% |
| Clene Inc(CLNNEUR) | COMMON STOCK | 185634102 | $3.7M | 4,240,846 | 2.5% |
| Ikena Oncology Inc | COM | 45175G108 | $3.7M | 558,000 | 2.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.3M | 382,000 | 2.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $2.9M | 244,828 | 2.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.7M | 141,755 | 1.8% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $2.2M | 300,000 | 1.5% |
| Roivant Sciences LTD(ROIV) | SHARES | G76279101 | $2.2M | 220,000 | 1.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.1M | 104,500 | 1.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 44,689 | 0.9% |
| Aclaris Therapeutics(ACRS) | COM | 00461U105 | $1.3M | 121,692 | 0.9% |
| Hillevax Inc | COM | 43157M102 | $1.1M | 63,078 | 0.7% |
| Morphic Holding Inc | COM | 61775R105 | $1.0M | 17,500 | 0.7% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $980.7K | 27,500 | 0.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $955.5K | 105,814 | 0.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $878.0K | 40,000 | 0.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $821.3K | 73,000 | 0.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $739.3K | 373,400 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $633.1K | 198,139 | 0.4% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $541.8K | 315,000 | 0.4% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $15.0K | 90,832 | 0.0% |